Articles by Keyword for

Zometa, a bisphosphonate drug used to prevent bone metastases in women with breast cancer, was serendipitously found to reduce metastases and extend life by 37%. This translates to 4-5 out of 100 being alive 7 years later. An IV infusion was given every six months for 3 years. Cost is between $1500 and $2500 per injection. All patients were early-stage and had...